Cyclosporine (CsA) and some of its metabolites (M9, M17, M18, M21) hav
e been determined by means of an LC-MASS method in eight psoriatic pat
ients developing nephrotoxicity. In comparison with a control group (1
5 psoriatics who after the same period of time, with the same daily do
se, did not develop nephrotoxicity) they showed an increase of CsA met
abolites, especially M17. Because M17 blood concentrations in the neph
rotoxic group tended to be higher than in the control group from the f
irst week of treatment we suggest that M17 might be considered a marke
r of ongoing nephrotoxicty. (C) 1996 The Italian Pharmacological Socie
ty